[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.163.166.22. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Citations 0
Letters
February 1, 2006

Atypical Antipsychotic Drugs, Dementia, and Risk of Death

Author Affiliations
 

Letters Section Editor: Robert M. Golub, MD, Senior Editor.

JAMA. 2006;295(5):495-497. doi:10.1001/jama.295.5.495-b

To the Editor: In their meta-analysis, Dr Schneider and colleagues1 present evidence of a small but significant increase in the risk of death when antipsychotic drugs are used to treat neuropsychiatric symptoms in older adults with dementia. This risk develops quickly and is consistent across trials evaluating different antipsychotic agents. Antipsychotic drugs are used in a variety of treatment settings. For several reasons, the results of this meta-analysis may have implications for the safety of antipsychotic use in the setting of delirium treatment.

First Page Preview View Large
First page PDF preview
First page PDF preview
×